Peer-Reviewed Research

29 Papers at
NeurIPS 2026 Workshops.

Peer-reviewed computational methods for drug discovery, toxicology and genomics. 29 accepted papers across 10 NeurIPS 2026 workshops · 16 AAIC 2026 certified abstracts · 15 accepted at AD/PD 2027.

NeurIPS 2026 · 29 workshop papers AAIC 2026 · 16 certified AD/PD 2027 · 15 accepted AAAI 2026 Bridge
NeurIPS 2026 Workshops

29 Papers Accepted Across 10 Workshops

Drug discovery, biomedical agents, and biological reasoning. All accepted to NeurIPS 2026 workshops (Vancouver, December 2026).

29
NeurIPS 2026 Workshops
10
Workshop Tracks
16
AAIC 2026 Certified
15
AD/PD 2027 Accepted
NeurIPS 2026 workshops — Drug Discovery & Biomedical 5 papers

AI4DD workshop · Biomedical AI for drug design and biological discovery

NeurIPS · AI4DDWorkshop site WORKSHOP
A quarter of ChEMBL's potency labels are bounds — and deleting them costs more than keeping them
Drug DiscoveryData Quality
NeurIPS · AI4DDWorkshop site WORKSHOP
Did Feedback Cause the Gain? A Factored Replay Audit for Molecular Acquisition
Drug DiscoveryMolecular Design
NeurIPS · AI4DDWorkshop site WORKSHOP
Intra-record consistency measures provenance, not curation quality: a refuted audit of TTD
Drug DiscoveryDatabase Audit
NeurIPS · AI4DDWorkshop site WORKSHOP
The Generator Is the Shift: A Cost Audit of Conformal Molecular Search
Drug DiscoveryMolecular Search
NeurIPS · AI4DDWorkshop site WORKSHOP
The TDC Lipophilicity benchmark is one assay — and a predictor that fits nothing retrieves 834 of 840 held-out labels exactly
Drug DiscoveryBenchmark AuditReproducibility
NeurIPS 2026 workshops — Biomedical Agents & Reasoning 24 papers

Agentic scientific workflows, continual learning, forecasting, and biomedical reasoning across 9 NeurIPS 2026 workshops.

Agentic AI for Biological Discovery (AgenticLS) · 11 workshop papers

Foundation Models for Temporal Systems (FMTS) · 4 workshop papers

NeurIPS · FMTSWorkshop siteWORKSHOP

Replication and Delayed Feedback in Forecasting Ensembles

ForecastingFoundation Models
NeurIPS · FMTSWorkshop siteWORKSHOP

Scenario Diversity Is Not Failure Foresight: A Frozen Audit of Quality-Diversity Scenario Libraries

ForecastingQuality-Diversity
NeurIPS · FMTSWorkshop siteWORKSHOP

A Self-Improving Forecasting Agent That Chooses Its Own Validation Window: Design Rules from a Two-Stage Pre-Registered Study

ForecastingSelf-Improvement
NeurIPS · FMTSWorkshop siteWORKSHOP

Ranking Is Not a Deployment Policy: Coverage Drift in Learned Reliability Gates for Prediction-Market Inputs

ForecastingDeployment

AI4Science · ASCI · CL4FMAgents · CLEA · CWM · NEmo · AI4ChipDesign · 9 workshop papers

NeurIPS · AI4ScienceWorkshop siteWORKSHOP

Auditing Recursive Model Promotion: Gate Interfaces, Decision Coverage, and Rejection Memory

AI for ScienceModel Auditing
NeurIPS · AI4ScienceWorkshop siteWORKSHOP

Count Every Validation: Auditing Hidden Attempts in Recursive AI Scientists

AI for ScienceValidation
NeurIPS · ASCIWorkshop siteWORKSHOP

Evidence-Gated Claim Ledgers: A Reporting Standard for Pathology Foundation Models

Biomedical AIFoundation Models
NeurIPS · CL4FMAgents ↗PDFWORKSHOP

A Retention-Gated Self-Evolving Memory for LLM Agents: Pre-Registered Backward-Transfer Evidence and Design Rules

Continual LearningMemory
NeurIPS · CLEA ↗PDFWORKSHOP

Change Passports: A Machine-Readable Standard for Auditable Artifact Promotion in Continually-Learning Agents

Continual LearningAuditability
NeurIPS · CWMWorkshop siteWORKSHOP

Belief Ledgers: Claim-Level Continual Revision for World Models

World ModelsContinual Learning
NeurIPS · NEmo ↗PDFWORKSHOP

Recursive World-Model Self-Repair in PDDL Domains: Verifier Coverage Is the Binding Constraint, and Under-Verified Loops Stall Rather Than Diverge

World ModelsSelf-Repair

NeurIPS 2025 workshop · AI for Drug Discovery and Development (AI4D3) · 1 paper

Alzheimer's Research

Clinical Alzheimer's Abstracts

Certified in-person posters at AAIC 2026 and accepted abstracts at AD/PD 2027. Biology-first credentials for the neuroimmunology and biomarker community.

AAIC 2026 — London 16 certified in-person posters · July 2026
AAIC 2026 · LondonConference sitePOSTER

Fluid Biomarkers of Pericyte Injury for Precision Vascular Subtyping

Biomarkers
AAIC 2026 · LondonConference sitePOSTER

Neuro-Symbolic AI for Alzheimer's Disease: Physics-Informed Biomarker Prediction and Verifiable Intervention Planning

Biomarkers
AAIC 2026 · LondonConference sitePOSTER

Neuro-Symbolic Recursive Self-Verification for Alzheimer's Disease Modeling: Anchoring AI in Biological Physics

Biomarkers
AAIC 2026 · LondonConference sitePOSTER

Reinforcement Learning with World Models for Optimizing Alzheimer's Disease Treatment Timing and Dosing

Drug Development
AAIC 2026 · LondonConference sitePOSTER

Reinforcement Learning from Verifiable Rewards in CNS Drug Optimization

Drug Development
AAIC 2026 · LondonConference sitePOSTER

Co-Evolving Virtual Cell Models and Perturbation Planners for Alzheimer's Disease Drug Discovery

Drug Development
AAIC 2026 · LondonConference sitePOSTER

Execution-Grounded AI Scientist for Autonomous Alzheimer's Drug Target Discovery

Drug Development
AAIC 2026 · LondonConference sitePOSTER

Coherence-Validated Causal World Models for Multi-Scale Alzheimer's Disease Progression and Pharmacologic Reversal

Drug Development
AAIC 2026 · LondonConference sitePOSTER

AI-Driven Physicochemical Optimization of Allosteric NAMPT Modulators: From Generative Chemistry to Brain-Penetrant Therapeutics

Drug Development
AAIC 2026 · LondonConference sitePOSTER

Recursively Optimizing AI Swarms for Precision Target Discovery: A Persistent-Memory Approach to Neurodegeneration

Basic Science & Pathogenesis
AAIC 2026 · LondonConference sitePOSTER

Dynamic Causal Discovery: Open-Ended Mapping of Neuroinflammatory Pathways

Basic Science & Pathogenesis
AAIC 2026 · LondonConference sitePOSTER

Iterative Self-Critique for Uncovering Cryptic Epistasis in Alzheimer's: Multi-Hop Genomic Reasoning via Monte Carlo Tree Search

Basic Science & Pathogenesis
AAIC 2026 · LondonConference sitePOSTER

Self-Improving Discovery Agents in AI-Driven Neurodegenerative Disease Research

Basic Science & Pathogenesis
AAIC 2026 · LondonConference sitePOSTER

Hierarchical Disease-State Generators for Neurodegenerative Genomics: Simulating Multi-Omic Interventions

Basic Science & Pathogenesis
AAIC 2026 · LondonConference sitePOSTER

Neuro-Symbolic Ideation Engines for Alzheimer's Therapeutics: Preventing Biological Hallucinations in Autonomous Discovery

Basic Science & Pathogenesis
AAIC 2026 · LondonConference sitePOSTER

Test-Time Scaling and Self-Verification for Precision Alzheimer's Diagnostics: Thinking Slower to Think Better

Clinical Manifestations
AD/PD 2027 — Barcelona 15 accepted abstracts · March 2027
AD/PD 2027 · BarcelonaConference siteACCEPTED

Plasma-CSF Concordance of 129 Neurodegeneration Proteins: Only pTau-217 Variants Translate

Biomarkers
AD/PD 2027 · BarcelonaConference siteACCEPTED

Plasma pTau217 Platforms Perform Equivalently and Outperform pTau181 for Detecting CSF Amyloid Positivity

Biomarkers
AD/PD 2027 · BarcelonaConference siteACCEPTED

Plasma pTau217, Aβ42-to-Aβ40 Ratio, NfL, and GFAP Improve CSF Amyloid-Positivity Discrimination Beyond Clinical and Genetic Predictors

Biomarkers
AD/PD 2027 · BarcelonaConference siteACCEPTED

Cross-Platform CSF Proteomics: ACHE and YWHAE Replicate on Aptamer and Mass-Spectrometry Platforms

Proteomics
AD/PD 2027 · BarcelonaConference siteACCEPTED

CSF proteomics study · title available on request

Proteomics
AD/PD 2027 · BarcelonaConference siteACCEPTED

Serum Phosphatidylcholines and Serotonin Differ in Alzheimer Dementia But Add No Incremental Classification Value

Metabolomics
AD/PD 2027 · BarcelonaConference siteACCEPTED

Network Propagation from Alzheimer-Associated Genes Enriches Therapy Controls and Prioritizes Kinase and Phagocytosis Pathways

Genomics
AD/PD 2027 · BarcelonaConference siteACCEPTED

Gradient Boosting Matches Leading TADPOLE Challenge Submissions for Diagnosis But Not for ADAS-COG13 Forecasting

Disease progression modelling
AD/PD 2027 · BarcelonaConference siteACCEPTED

Causal Multimodal Digital Twins for Treatment-Relevant Neurodegeneration Trajectories

Disease progression modelling
AD/PD 2027 · BarcelonaConference siteACCEPTED

Group-Conditional Conformal Calibration Improves APOE4 Homozygote Coverage in Twenty-Four-Month Alzheimer Prognosis

Prognosis
AD/PD 2027 · BarcelonaConference siteACCEPTED

AI-Assisted Protocol Red-Teaming for Alzheimer's and Parkinson's Clinical Trials

Clinical trials
AD/PD 2027 · BarcelonaConference siteACCEPTED

Recursive Causal Discovery for Intervention-Relevant Alzheimer's and Parkinson's Targets

Target discovery
AD/PD 2027 · BarcelonaConference siteACCEPTED

Recursive Self-Driving Laboratories for Grounded Alzheimer's and Parkinson's Discovery

Drug discovery
AD/PD 2027 · BarcelonaConference siteACCEPTED

Neuro-Symbolic Falsification for Auditable Alzheimer's and Parkinson's Therapeutic Science

Drug discovery
AD/PD 2027 · BarcelonaConference siteACCEPTED

A Self-Improving Multimodal Design Stack for Neurodegenerative Therapeutics

Drug discovery
April 2026
ICLR 2026 Workshops 10 papers

Genomics & Perturbation Biology, Computational Systems Biology, and Neuro-Symbolic Reasoning workshops at ICLR 2026.

Genomics & Perturbation Biology ↗PDFWORKSHOP

Hierarchical Disease-State Generators for Neurodegenerative Genomics: A Benchmark Proposal for Intervention-Conditioned Multi-omic Generation

GenomicsAlzheimer'sMulti-omics
Computational Systems Biology ↗PDFWORKSHOP

Reinforcement Learning with World Models for Optimizing Alzheimer's Disease Treatment Timing and Dosing

Alzheimer'sRLTreatment Optimization
Computational Systems Biology ↗PDFWORKSHOP

Coherence-Validated Causal World Models for Multi-Scale Alzheimer's Disease Progression and Pharmacologic Reversal

Alzheimer'sCausal AIReversal Trajectories
Neuro-Symbolic Reasoning ↗PDFWORKSHOP

Neuro-Symbolic Active Causal Hypothesis Testing for NAD+-Centered Alzheimer's Disease Reversal

Alzheimer'sNAD+Neuro-Symbolic
Neuro-Symbolic Reasoning ↗PDFWORKSHOP

Latent-Implicit Thinking with Proof-Carrying Neuro-Symbolic Outputs for Biomedical Discovery

Biomedical AINeuro-SymbolicLatent Reasoning
Neuro-Symbolic Reasoning ↗PDFWORKSHOP

Autoformalizing Biomedical Text into Verified Knowledge Graph Reasoning: A Neuro-Symbolic Architecture for Alzheimer's Disease

Alzheimer'sKnowledge GraphsAutoformalization
Genomics & Foundation Models ↗PDFWORKSHOP

Active Learning for Optimal Experimental Design in Alzheimer's Disease Drug Discovery: Prioritizing NAD+-Enhancing Therapeutic Analogs via Multi-Objective Bayesian Optimization

Alzheimer'sActive LearningNAD+
Genomics & Foundation Models ↗PDFWORKSHOP

Agentic Active Causal Discovery for Alzheimer's Disease Reversal: Closing the Genomic Experimental Loop

Alzheimer'sCausal DiscoveryGenomics
Genomics & Foundation Models ↗PDFWORKSHOP

Uncertainty-Aware Biomarker Discovery for Alzheimer's Disease Reversal: Bridging Mouse Models and Human Translation with Conformal Prediction

Alzheimer'sBiomarkersConformal Prediction
AAAI 2026 & Earlier Venues 2 papers + 1 talk
AAAI 2026 Bridge · LMReasoning ↗PDFORAL

Neuro-Symbolic AI for Alzheimer's Disease: Physics-Informed Biomarker Prediction and Verifiable Intervention Planning

Alzheimer'sBiomarker Prediction
AAAI 2026 Workshop · AIDDWorkshop siteORAL

Agentic Causal Graph Learning for Drug Target Discovery: A Self-Directed AI System at STRING Scale

Drug DiscoveryCausal Graph
IROS 2025 · AIR4SWorkshop sitePERSPECTIVE TALK

Building a Robot Scientist: From Reasoning Models to Autonomous Discovery

Robot ScientistAutonomous Discovery

Accelerating Biomedical Insight

Our research is grounded in real-world biological complexity — drug discovery, toxicology and genomics. Contact us to learn how our validated methods can support your therapeutic pipeline.

Request Report